S. Korea to nurture healthcare sector based on 4th industrial revolution
S. Korea to nurture healthcare sector based on 4th industrial revolution
  • Kim Sua
  • 승인 2018.12.10 13:12
  • 댓글 0
이 기사를 공유합니다

South Korea will lead the healthcare industry by making full use of cutting-edge technologies, such as big data and artificial intelligence (AI), that are shaping the fourth industrial revolution, the health ministry said on Dec. 10, 2018.

The Ministry of Health and Welfare mapped out a blueprint with an aim of transforming the country into a global biotech and medical industry hub. The plan was finalized during a meeting by a presidential committee on the fourth industrial revolution.

Ministry of Health and Welfare sign in Sejong, central South Korea.

The committee has operated a taskforce team, comprised of officials from four different ministries and experts from the industrial sector, to map out the comprehensive plan following concerns over a lack of a coordinated strategy and overlapping projects by government offices and relevant institutions.

"Major changes are happening in the healthcare industry due to never-before-seen technologies," Health and Welfare Minister Park Neung-hoo said. "The blueprint is focused on providing better service for the people."

The ministry said it will expand investment in research and development (R&D) in medicine, medical devices and cosmetics, as upwards to 940,000 new jobs could be created in these areas by 2020.

The global market for precision medicine, considered one of the centerpieces of the fourth industrial revolution, is forecast to log annual growth of 15.2 percent between 2021 and 2025.

Under the plan, the government will first push forward the establishment of healthcare big data that encompasses health and genetic data on people, including survivors of cancer, by 2021.

The government will also push forward a project to develop a drug platform based on AI and big data in an effort to speed up drug discovery.

The ministry forecasts the global healthcare AI market to log annual growth of 52.7 percent from 2016 to 2022.

The platform will eventually decrease failure rates in clinical, and downsize research and development costs in the process, officials said.

The researchers will work on the development of AI-supported platforms to search for possible candidate substances for new drugs that can precisely predict interactions between compounds, officials said.

The interaction between various compounds is an important consideration in both drug development and clinical application as it can help prevent potentially dangerous side effects.

The government said it will develop a comprehensive system that can monitor all clinical trials in an effort to improve efficacy and quality.

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.